Author

Pablo Floriano

Observed names: P Floriano, P. Floriano

Institution: PharmaMar (Spain)

Observed institution: PharmaMar (Spain)

OpenAlex ID: A5035072011

Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

1998 · H. Rosing, M. J. X. Hillebrand, et al. · Journal of Mass Spectrometry · 48

Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.

2000 · B Nuijen, M Bouma, et al. · PubMed · 28

Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction

1998 · H Rosing, M.J.X Hillebrand, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 22

Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4′-hydrazino-2-stilbazole

1999 · Rolf W Sparidans, J.Jantien Kettenes-van den Bosch, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 19

Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin®, a novel marine‐derived antineoplastic agent, in human plasma

2003 · Jianming Yin, Pablo Aviles, et al. · Rapid Communications in Mass Spectrometry · 15

Phenylisothiocyanate and dansyl chloride precolumn derivatizations for the high-performance liquid chromatography analysis of the antitumoral agent ES-285 in dog plasma

2003 · C Maraschiello, E Miranda, et al. · Journal of Chromatography B · 14

Bioanalysis of thiocoraline, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography and fluorescence detection

1999 · Rolf W Sparidans, Roland E.C Henrar, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 9

Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285·HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form

2003 · Monique W.J den Brok, Bastiaan Nuijen, et al. · Journal of Chromatography A · 8

Hplc-uv Method Development and Impurity Profiling of the Marine Anticancer Agent Aplidine in Raw Drug Substance and Pharmaceutical Dosage Form

2001 · B. Nuijen, I. M. Rodrigues-Campos, et al. · Journal of Liquid Chromatography & Related Technologies · 8

Development of an Hplc Method With Uv Detection for the Pharmaceutical Quality Control of the Novel Marine Anticancer Agent Kahalalide F

2001 · B. Nuijen, M. Bouma, et al. · Journal of Liquid Chromatography & Related Technologies · 5

Enantioselective LC/MS method for the determination of an antimalarial agent Fenozan B07 in dog plasma

2006 · Ciriaco Maraschiello, Jaume Vilageliu, et al. · Chirality · 2

Erratum to “Development and validation of a liquid chromatography–ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285·HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form” [J. Chromatogr. A 1020 (2003) 251–258]

2004 · Monique W.J. den Brok, Bastiaan Nuijen, et al. · Journal of Chromatography A

Works count: 12

Citation count: 178

H-index: 8

I10-index: 6